Advertisements



"No Mask, No Hose, No Noise": Inspire Is Disrupting Sleep Apnea Treatment

"No Mask, No Hose, No Noise": Inspire Is Disrupting Sleep Apnea Treatment.....»»

Category: topSource: seekingalphaOct 11th, 2018

Inspire Medical"s therapy for treatment of sleep apnea approved in Japan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 27th, 2018

ResMed Launches AirFit P30i Nasal Pillows Mask in the US

ResMed (RMD) to expand its portfolio of sleep apnea devices on the ba.....»»

Category: dealsSource: nytApr 12th, 2019

Sleep-apnea device maker Inspire Medical sets terms for IPO

Med-tech company Inspire Medical Systems Inc. set terms for its initial public offering Monday, proposing a price range that would generate between $70 million and $80 million in proceeds. The Maple Grove-based company said Monday it will sell 5 million.....»»

Category: topSource: bizjournalsApr 23rd, 2018

Biotech advances changing surgical possibilities

Beginning in April, Erie County Medical Center surgeons will be able to offer a new option: a surgically implanted device that uses neurostimulation therapy to treat sleep apnea......»»

Category: topSource: bizjournalsMar 21st, 2019

FDA approves Jazz Pharmaceutical sleep disorder drug

The Food and Drug Administration approved Jazz Pharmaceutical's new drug application for Sunosi, a once-daily medicine designed to improve wakefulness in adult patients suffering from narcolepsy and obstructive sleep apnea. Sunosi is expected to.....»»

Category: topSource: bizjournalsMar 20th, 2019

Can ResMed (RMD) Repeat Stable Device Growth in Q3 Earnings?

ResMed's (RMD) sleep apnea patient volume consistently witnesses a steady expansion. We expect this upside to continue in the fiscal third quarter as well. ResMed Inc. RMD is slated to report third-quarter fiscal 2018 results after m.....»»

Category: topSource: zacksApr 19th, 2018

Medical Marijuana Shouldn"t Be Used to Treat Common Sleep Disorder, Experts Warn

Almost 30 million adults in the U.S. have obstructive sleep apnea......»»

Category: topSource: newsweekApr 16th, 2018

These Bose earbuds are meant to put you to sleep

Most Bose headphones are designed to be heard. But Sleepbuds instead mask .....»»

Category: topSource: usatodayJun 20th, 2018

Cristiano Ronaldo had to go to his hotel window to quiet Iran fans down the night before a huge match

Reuters Iranian fans gathered outside of Portugal's hotel and made noise to keep them from sleeping. Eventually, Cristiano Ronaldo got up and went to the hotel window and pleaded with fans to let them sleep. Portugal and Iran play in a mus.....»»

Category: topSource: businessinsiderJun 25th, 2018

ResMed, Verily announce joint venture focusing on sleep apnea

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2018

Alphabet Roundup: Healthcare, Shopify, Payments, Regulatory

Alphabet joined ResMed to form a startup focused on sleep apnea, partnered with Shopify to deliver better ad tools, merged Google Pay Send into Google Pay even as it was fined $5 billion by the EU. Alphabet GOOGL.....»»

Category: dealsSource: nytJul 23rd, 2018

Can Bose"s noise-masking Sleepbuds really help you sleep?

Can Bose"s noise-masking Sleepbuds really help you sleep?.....»»

Category: topSource: washpostJul 26th, 2018

8 sleep aids that tackle nighttime noise complaints like snoring — from Bose’s new $250 Sleepbuds to a $2 app

The Insider Picks team writes about stuff we think .....»»

Category: topSource: businessinsiderSep 5th, 2018

Bose now makes $250 noise-masking Sleepbuds that are comfortable enough for side sleepers — here"s how they stacked up against NYC"s noise

The Insider Picks team writes about stuff we think you'll like. Business Insider has affiliate partnerships, so we get a share of the revenue from your purchase. Bose Bose's $250 Sleepbuds are tiny wireless earbuds that mask exte.....»»

Category: topSource: businessinsiderSep 6th, 2018

More Than Just Counting Hours: How Sleep Apnea Plays Into Driver Fatigue

Fatigue is one of the most common health and safety concerns among drivers on the road, and while sleep loss often plays a role in feeling fatigued, counting hours doesn't always tell the whole story. read more.....»»

Category: blogSource: benzingaNov 9th, 2018

Axovant shares slide 24% premarket after trial of treatment for sleep disorder fails to meet main goal

Axovant Sciences Ltd. shares slid 24% in premarket trade Monday, after the company said a trial of a treatment for REM sleep behavior disorder in patients with Lewy body dementia failed to meet its main goal. the Basel, Switzerland-base.....»»

Category: topSource: marketwatchDec 10th, 2018

UPDATE: Axovant shares slide 30% premarket after trial of treatment for sleep disorder fails to meet main goal

Axovant Sciences Ltd. shares slid 30% in premarket trade Monday, after the company said a trial of a treatment for REM sleep behavior disorder in patients with Lewy body dementia failed to meet its main goal. the Basel, Switzerland-base.....»»

Category: topSource: marketwatchDec 10th, 2018

Drug stock soars 250% on pneumonia treatment review

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review......»»

Category: topSource: moneycentral7 hr. 37 min. ago

Drug stock soars 250 percent on pneumonia treatment review

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review......»»

Category: topSource: moneycentral11 hr. 38 min. ago

Drug stock soars 250 percent on pneumonia treatment review

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review......»»

Category: topSource: moneycentral11 hr. 38 min. ago